Particle.news

Download on the App Store

Study Finds Faster Antibody Response When COVID Boosters Are Administered in Same Arm

New research in Cell highlights how consistent injection sites activate memory B cells in nearby lymph nodes, accelerating early immunity without affecting long-term protection.

Image
Beim Impfen werden wir oft gefragt, in welchen Arm die Spritze injiziert werden soll? Bei der Booster-Impfung macht das tatsächlich einen Unterschied. © mapo/iStock

Overview

  • Research led by Tri Phan and published in Cell demonstrates that administering COVID-19 booster doses in the same arm triggers faster antibody production within a week.
  • The study reveals that memory B cells remain in lymph nodes near the injection site, enabling enhanced immune activation when boosters are given in the same arm.
  • Initial findings from mouse models were validated in a human study involving 30 participants using the BioNTech COVID-19 vaccine.
  • Experts reassure that long-term immunity equalizes regardless of the arm used for injections, alleviating concerns for those who alternated arms.
  • The findings, coinciding with European Immunization Week, may inform future vaccine strategies, though further studies are needed to assess the effect's duration and broader clinical significance.